Insider trades
Lewis H. Titterton Jr., Director of Anixa Biosciences ANIX, has filed 20 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $1.1M. The latest trade was on 09/23.
Lewis H. Titterton Jr.
Director
- Company
- Anixa Biosciences ANIX
- First filing
- 23/01/04
- Trades
- 52 trades
- Buys / sales
- 20 / 0
- 12-month net buying
- $1.1M
- Last trade
- 09/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 09/23 | 09/25 | 49,036 sh | $2.69 | $131,906.84 | +4.9% | |
| Open-market buy | 06/16 | 06/17 | 2,836 sh | $2.64 | $7,487.04 | +0.3% | |
ParkervisionPRKR | Open-market buy | 25/11/18 | 25/11/18 | 4,761,905 sh | $0.21 | $1,000,000.05 | +124.8% |
| Open-market buy | 25/07/31 | 25/08/04 | 10,000 sh | $3.08 | $30,800 | +1.1% | |
| Open-market buy | 25/07/11 | 25/07/15 | 10,000 sh | $3.14 | $31,400 | +1.1% | |
| Open-market buy | 25/01/23–25/01/24 | 25/01/27 | 3,000 sh2 trades | $2.94avg. | $8,820 | +0.3% | |
| Open-market buy | 25/01/22 | 25/01/23 | 2,000 sh | $3.01 | $6,020 | +0.2% | |
| Open-market buy | 25/01/21 | 25/01/22 | 6,000 sh | $2.59 | $15,540 | +0.7% | |
| Open-market buy | 25/01/17 | 25/01/17 | 10,000 sh | $2.57 | $25,700 | +1.1% | |
| Open-market buy | 24/07/30–24/07/31 | 24/08/01 | 27,226 sh2 trades | $3.09avg. | $84,260.16 | +3.1% | |
| Open-market buy | 24/07/25–24/07/26 | 24/07/29 | 8,496 sh2 trades | $3.01avg. | $25,567.76 | +1.0% | |
| Open-market buy | 24/06/14 | 24/06/18 | 4,000 sh | $2.68 | $10,720 | +0.5% | |
| Open-market buy | 24/06/13 | 24/06/14 | 405 sh | $2.70 | $1,093.5 | +0.0% | |
| Open-market buy | 24/06/10–24/06/11 | 24/06/12 | 7,432 sh2 trades | $2.66avg. | $19,749.32 | +0.9% | |
| Open-market buy | 24/06/07 | 24/06/10 | 10,738 sh | $2.52 | $27,059.76 | +1.3% | |
| Open-market buy | 24/04/09 | 24/04/10 | 15,009 sh | $3.28 | $49,229.52 | +1.8% |